What is Dogwood Therapeutics's net investment in lease?

Dogwood Therapeutics (DWTX) reported net investment in lease of $146.75K in Q1 2026.

How has Dogwood Therapeutics's net investment in lease changed year-over-year?

Dogwood Therapeutics's net investment in lease decreased by 24.3% year-over-year, from $193.76K to $146.75K.

Dogwood Therapeutics DWTX Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

Collegium Pharmaceutical, Inc.COLL

——

BioventusBVS

——

Avanos MedicalAVNS

——

LON

LeonaBio, Inc. Common StockLONA

——

Amylyx Pharmaceuticals, Inc.AMLX

——

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's net investment in lease?: Dogwood Therapeutics (DWTX) reported net investment in lease of $146.75K in Q1 2026.
How has Dogwood Therapeutics's net investment in lease changed year-over-year?: Dogwood Therapeutics's net investment in lease decreased by 24.3% year-over-year, from $193.76K to $146.75K.